The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
3.730
+0.060 (1.63%)
At close: Aug 1, 2025, 4:00 PM
3.790
+0.060 (1.61%)
After-hours: Aug 1, 2025, 7:34 PM EDT
Accolade Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Accolade stock has a target of 6.00, which predicts a 60.86% increase from the current stock price of 3.73.
Price Target: $6.00 (+60.86%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Accolade is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B. Riley Securities | B. Riley Securities | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +60.86% | Jul 16, 2025 |
Jefferies | Jefferies | Strong Buy Initiates $2.5 | Strong Buy | Initiates | $2.5 | -32.98% | Feb 26, 2024 |
Guggenheim | Guggenheim | Strong Buy Maintains $3 → $2 | Strong Buy | Maintains | $3 → $2 | -46.38% | Jun 16, 2023 |
Guggenheim | Guggenheim | Hold Maintains $6 → $3 | Hold | Maintains | $6 → $3 | -19.57% | Mar 20, 2023 |
Guggenheim | Guggenheim | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +60.86% | Nov 11, 2022 |
Financial Forecast
Revenue This Year
469.75M
from 393.41M
Increased by 19.40%
Revenue Next Year
n/a
from 469.75M
EPS This Year
-0.16
from -0.71
EPS Next Year
n/a
from -0.16
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 |
---|---|
High | 491.5M |
Avg | 469.8M |
Low | 452.9M |
Revenue Growth
Revenue Growth | 2025 |
---|---|
High | 24.9% |
Avg | 19.4% |
Low | 15.1% |
EPS Forecast
EPS | 2025 |
---|---|
High | -0.17 |
Avg | -0.16 |
Low | -0.16 |
EPS Growth
EPS Growth | 2025 |
---|---|
High | - |
Avg | - |
Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.